ELN and triple-A syndrome: An alternative hydroxamate-based MMP antagonist, RS 132908, also suppressed aortic dilatation in a rat intraluminal elastase-perfusion AAA model, preserving medial elastin integrity and exerting a medial pro-fibrotic response, although no effect on inflammation was observed (178).